Trilogene Seeds unveiled their new line of triploid THCa seeds.
The introduction of triploid genetics in cannabis, a concept previously applied to other agricultural crops like seedless watermelons, affords benefits for indoor and outdoor growers, extractors, and consumers. Triploids, with an additional set of chromosomes, are essentially sterile, channeling energy towards more desirable traits rather than seed development. This sterility also eliminates the risk of cross-pollination, ensuring consistency and quality in cannabinoid levels. Despite the common misconception, triploid seeds are not genetically-modified organisms (GMO).
Polyploidy genetics, the condition of having more than two sets of chromosomes, plays a pivotal role in the evolution and diversification of plants by introducing genetic variability and increased complexity. This genetic phenomenon is particularly significant in the context of triploid seeds, where the organism possesses three sets of chromosomes, resulting in sterility and directing the plant's resources towards enhancing traits such as growth, metabolite production, and in the case of cannabis, potentially increased volatile compounds and trichome density, thus, offering a compelling approach to optimizing cannabis cultivation for both commercial and research purposes.
"We take an approach that prioritizes integrity and rigorous scientific validation, pushing forward innovation within the cannabis industry," said Matthew Haddad, CEO and Founder of Trilogene Seeds. "Together with our lead Chief Science Officer, Oussama Badad, we are committed to leading the charge in research and development, ensuring that every breakthrough we achieve is grounded in solid science and brings tangible benefits to our customers and the wider cannabis community. Our mission is to amplify approaches that are not only scientifically sound but also ethically responsible, driving progress that uplifts the entire industry."
For more information:
Trilogene Seeds 
www.trilogeneseeds.com